93 related articles for article (PubMed ID: 587586)
21. [Effects of methamphetamine and a reserpine-like drug on norepinephrine and dopamine metabolism in the rat brain].
Nozu T; Furukawa T
Nihon Yakurigaku Zasshi; 1976 May; 72(4):445-51. PubMed ID: 1049210
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
23. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
Cegrell L
Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
[No Abstract] [Full Text] [Related]
24. Modification of PGO activity by specific uptake inhibitors fluoxetine, nisoxetine and LR5182.
Neal H; Bond A
Neuropharmacology; 1979 Oct; 18(10):813-9. PubMed ID: 160019
[No Abstract] [Full Text] [Related]
25. Liberation of catecholamines from blood platelets.
Pletscher A
Br J Pharmacol; 1981 Feb; 72(2):349-54. PubMed ID: 6452188
[TBL] [Abstract][Full Text] [Related]
26. Possible neurotransmitter role of noradrenaline in the teleost retina.
Jaffe EH; Urbina M; Drujan BD
J Neurosci Res; 1991 Jun; 29(2):190-5. PubMed ID: 1679856
[TBL] [Abstract][Full Text] [Related]
27. Uptake and liberation of mepacrine in blood platelets.
Picotti GB; Da Prada M; Pletscher A
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):127-31. PubMed ID: 1047793
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Fuller RW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
[TBL] [Abstract][Full Text] [Related]
29. [Effects of lithium chloride administered in combination with methamphetamine or a reserpine- like drug on brain norepinephrine and dopamine metabolism in rats].
Nozu T; Furukawa T
Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):715-23. PubMed ID: 1051410
[TBL] [Abstract][Full Text] [Related]
30. Dopamine metabolism following irreversible inactivation of aromatic amino acid decarboxylase in retina.
Parkinson D; Baughman R; Masland RH; Rando RR
J Neurosci; 1981 Nov; 1(11):1205-10. PubMed ID: 6796656
[TBL] [Abstract][Full Text] [Related]
31. Neural and hormonal control of catecholamine synthesis.
Axelrod J
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():229-40. PubMed ID: 4403654
[No Abstract] [Full Text] [Related]
32. Species differences in the distribution of substance P and tyrosine hydroxylase immunoreactivity in the olfactory bulb.
Baker H
J Comp Neurol; 1986 Oct; 252(2):206-26. PubMed ID: 2431012
[TBL] [Abstract][Full Text] [Related]
33. Treatment with a polyunsaturated fatty acid prevents deleterious effects of Ro4-1284.
Yehuda S; Rabinovitz S; Mostofsky DI
Eur J Pharmacol; 1999 Jan; 365(1):27-34. PubMed ID: 9988119
[TBL] [Abstract][Full Text] [Related]
34. Effect of Ro 4-1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats.
Jobe PC; Brown RD; Dailey JW
Life Sci; 1981 May; 28(18):2031-8. PubMed ID: 6909499
[No Abstract] [Full Text] [Related]
35. Neurochemical characterization of the alterations in the noradrenergic afferents to the cerebellum of adult rats exposed to X-irradiation at birth.
Dopico AM; Zieher LM
J Neurochem; 1993 Aug; 61(2):481-9. PubMed ID: 8101557
[TBL] [Abstract][Full Text] [Related]
36. On the role of storage granules in the functional utilization of newly synthesized dopamine.
Shore PA
J Neural Transm; 1976; 39(1-2):131-8. PubMed ID: 1049242
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]s.
Caroon JM; Clark RD; Kluge AF; Lee CH; Strosberg AM
J Med Chem; 1983 Oct; 26(10):1426-33. PubMed ID: 6312043
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a neurotransmitter role for 5-hydroxytryptamine in chick retina.
Parkinson D; Rando RR
J Neurosci; 1981 Nov; 1(11):1211-7. PubMed ID: 6118400
[TBL] [Abstract][Full Text] [Related]
39. Brain areas involved in the catecholamine mediated regulation of electroshock seizure intensity.
Stull RE; Jobe PC; Geiger PF
J Pharm Pharmacol; 1977 Jan; 29(1):8-11. PubMed ID: 13193
[TBL] [Abstract][Full Text] [Related]
40. Modulation of endogenous dopamine release in the fish retina by light and prolonged darkness.
Weiler R; Baldridge WH; Mangel SC; Dowling JE
Vis Neurosci; 1997; 14(2):351-6. PubMed ID: 9147486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
